Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Saik Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
03/23/2023 4 Saik Andrew (EVP & CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 909 shares @ $14.19, valued at $12.9k
01/31/2023 4 Saik Andrew (EVP & CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 14,700 shares @ $0
Granted 24,000 options to buy @ $18.4, valued at $441.6k
01/03/2023 4 Saik Andrew (EVP & CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 718 shares @ $12.37, valued at $8.9k
09/23/2022 4 Saik Andrew (EVP & CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 908 shares @ $14.85, valued at $13.5k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2022 4 Saik Andrew (EVP & CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 10,300 shares @ $0
Granted 17,600 options to buy @ $14.44, valued at $254.1k
06/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Saik Andrew (CFO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Granted 3,017 shares @ $3.3575, valued at $10.1k
04/02/2021 4 Saik Andrew (CFO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 762 shares @ $6.84, valued at $5.2k
02/24/2021 4 Saik Andrew (CFO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Granted 29,213 shares @ $0
Granted 68,162 options @ $8.33, valued at $567.8k
09/08/2020 4 Saik Andrew (CFO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Bought 40,000 shares @ $1.462, valued at $58.5k
05/08/2020 4 Saik Andrew (CFO) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Granted 250,000 shares @ $0
Granted 250,000 options @ $1.95, valued at $487.5k
03/24/2020 4 Saik Andrew (CFO) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Granted 50,000 shares @ $0
Granted 100,000 options @ $3.13, valued at $313k
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Saik Andrew (CFO) has filed a Form 4 on PDS Biotechnology Corp
Txns: Granted 62,715 options to buy @ $6.39, valued at $400.7k
03/18/2019 4 Saik Andrew (CFO) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Exercised 82,999 restricted stock units @ $0
08/15/2018 4 Saik Andrew (CFO) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Granted 82,999 restricted stock units @ $0
06/20/2018 4 Saik Andrew (CFO) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Granted 166,001 options to buy @ $1.1, valued at $182.6k
03/05/2018 4 Saik Andrew (CFO) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $14.98, valued at $749k
11/03/2017 4 Saik Andrew (CFO) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $10.73, valued at $2.1M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy